PPMA – event – sep 2018

Latest news

New treatment strategy for kidney cancer after driver discovery

New treatment strategy for kidney cancer after driver discovery

A potential therapeutic target for kidney cancers that have a common genetic change has been discovered by scientists at the University of North Carolina...
Latest US approval for Novartis’ Kisqali

Latest US approval for Novartis’ Kisqali

Novartis has gained new approval for Kisqali in the US for women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or...
Sanofi & Revolution Medicines developing targeted treatments for multiple cancers

Sanofi & Revolution Medicines developing targeted treatments for multiple cancers

Sanofi and Revolution Medicines have partnered to develop and commercialise targeted therapies, based on the biology of the cellular enzyme SHP2, for patients with...